Cornelis J.A. Punt

51.1k citations

392 papers · 24.3k indexed · 10 hit papers · h-index 73

Oncology top 0.02%
Immunology top 0.2%
Molecular Biology top 1%
Pulmonary and Respiratory Medicine top 0.2%
Cancer Research top 0.2%

Co-authors: Miriam Koopman I. Jolanda M. de Vries Carl G. Figdor W. Joost Lesterhuis Gosse J. Adema J. Han van Krieken Irıs D. Nagtegaal Jolien Tol
Topics: Colorectal Cancer Treatments and Studies (183 papers)Genetic factors in colorectal cancer (88 papers)Hepatocellular Carcinoma Treatment and Prognosis (61 papers)
Cited by: Oncology Hepatology Immunology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: Netherlands United States Germany

In The Last Decade

Cornelis J.A. Punt

386 papers receiving 23.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

2008 1.5k citations Cornelis J.A. Punt et al. Journal of Clinical Oncology profile →
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

2009 1.0k citations Jolien Tol, Miriam Koopman et al. profile →
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1998 973 citations Cornelis J.A. Punt et al. profile →
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

2010 755 citations Marc Peeters, Timothy Price et al. Journal of Clinical Oncology profile →
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

2005 666 citations I. Jolanda M. de Vries, W. Joost Lesterhuis et al. profile →
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

2014 534 citations Sabine Venderbosch, Irıs D. Nagtegaal et al. Clinical Cancer Research profile →
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

2022 501 citations Luis A. Díaz, Kai‐Keen Shiu et al. profile →
From tumour heterogeneity to advances in precision treatment of colorectal cancer

2016 439 citations Cornelis J.A. Punt, Miriam Koopman et al. profile →
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

2016 434 citations Tim Maughan, Michel Seymour et al. profile →
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

2017 414 citations Cornelis J.A. Punt, Eric Van Cutsem et al. profile →

Peers

Countries citing papers authored by Cornelis J.A. Punt

Since Specialization

Citations

This map shows the geographic impact of Cornelis J.A. Punt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis J.A. Punt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis J.A. Punt more than expected).

Fields of papers citing papers by Cornelis J.A. Punt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelis J.A. Punt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis J.A. Punt. The network helps show where Cornelis J.A. Punt may publish in the future.

Co-authorship network of co-authors of Cornelis J.A. Punt

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelis J.A. Punt. A scholar is included among the top collaborators of Cornelis J.A. Punt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelis J.A. Punt. Cornelis J.A. Punt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer 2023 ·ESMO Open ·Cornelis J.A. Punt,Volker Heinemann,Tim Maughan,Chiara Cremolini,Eric Van Cutsem,Ray McDermott,(unknown),Thierry André,Pia Österlund,Arco J. Teske,Per Pfeiffer	4
2	FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty 2022 ·ESMO Open ·(unknown),Oliver Todd,Peter Hall,(unknown),Aaron Quyn,Michel Seymour,Michael Braun,Jeanine M.L. Roodhart,Cornelis J.A. Punt,(unknown),Julien Taı̈eb,Mehdi Karoui,Julia Brown,David A. Cairns,Dion Morton,Alexandra Gilbert,Jenny F. Seligmann	5
3	O-8 Final overall survival for the phase 3 KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer 2021 ·Annals of Oncology ·Thierry André,Kai‐Keen Shiu,(unknown),Benny Vittrup Jensen,Lars Henrik Jensen,Cornelis J.A. Punt,Denis Smith,Rocio García‐Carbonero,Julia Alcaide,Peter Gibbs,Christelle de la Fouchardière,F. Rivera Herrero,Elena Élez,Johanna C. Bendell,Dung T. Le,Takayuki Yoshino,(unknown),David R. Fogelman,Patricia Marinello,Luis A. Díaz	1
4	The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology 2018 ·Journal of Clinical and Translational Research ·(unknown),Stephanie Medlock,(unknown),(unknown),Onno R. Guicherit,Cornelis J.A. Punt,Martijn G.H. van Oijen	9
5	WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy 2016 ·Clinical Cancer Research ·Linda J.W. Bosch,Yanxin Luo,Victoria Valinluck Lao,Pétur Snæbjörnsson,Geert Trooskens,Ilse Vlassenbroeck,Sandra Mongera,Weiliang Tang,Piri Welcsh,James G. Herman,Miriam Koopman,Irıs D. Nagtegaal,Cornelis J.A. Punt,Wim Van Criekinge,Gerrit A. Meijer,Raymond J. Monnat,Beatriz Carvalho,William M. Grady	6
6	T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines 2016 ·Cancer Research ·Angela Vasaturo,Altuna Halilović,Kalijn F. Bol,(unknown),Willeke A.M. Blokx,Cornelis J.A. Punt,Patricia J.T.A. Groenen,J. Han van Krieken,Johannes Textor,I. Jolanda M. de Vries,Carl G. Figdor	28
7	Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry 2016 ·Clinical Cancer Research ·Anne Trinh,Kari Trumpi,Felipe de Sousa e Melo,Xin Wang,Joan H. de Jong,Evelyn Fessler,Peter J.K. Kuppen,Marlies S. Reimers,Marloes Swets,Miriam Koopman,Irıs D. Nagtegaal,Marnix Jansen,Gerrit K. Hooijer,G. Johan A. Offerhaus,Onno Kranenburg,Cornelis J.A. Punt,Jan Paul Medema,Florian Markowetz,Louis Vermeulen	132
8	Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studiesbreakdown → 2014 ·Clinical Cancer Research ·Sabine Venderbosch,Irıs D. Nagtegaal,Tim Maughan,Christopher G. Smith,Jeremy P. Cheadle,David J. Fisher,Richard Kaplan,Philip Quirke,Michel Seymour,Susan D. Richman,Gerrit A. Meijer,Bauke Ylstra,Daniëlle A.M. Heideman,Anton F. J. de Haan,Cornelis J.A. Punt,Miriam Koopman	534
9	Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients 2013 ·Cancer Research ·Jurjen Tel,Erik H.J.G. Aarntzen,Tetsuro Baba,Gerty Schreibelt,Barbara M. Schulte,Daniel Benítez‐Ribas,Otto C. Boerman,Sandra Croockewit,Wim J.G. Oyen,Michelle van Rossum,Gregor Winkels,Pierre G. Coulie,Cornelis J.A. Punt,Carl G. Figdor,I. Jolanda M. de Vries	289
10	Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma 2012 ·Journal of Clinical Oncology ·Alexander M.M. Eggermont,Stefan Suciu,Alessandro Testori,Mario Santinami,Wim H.J. Kruit,Jeremy Marsden,Cornelis J.A. Punt,François Salès,Reinhard Dummer,Caroline Robert,Dirk Schadendorf,(unknown),Gaetan de Schaetzen,Alan Spatz,Ulrich Keilholz	190
11	Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer 2012 ·Gut ·Leonie J. Mekenkamp,Josien Haan,Miriam Koopman,M. Elisa Vink-Börger,(unknown),Steven Teerenstra,Bauke Ylstra,Gerrit A. Meijer,Cornelis J.A. Punt,Irıs D. Nagtegaal	16
12	Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination 2012 ·Cancer Research ·Erik H.J.G. Aarntzen,I. Jolanda M. de Vries,W. Joost Lesterhuis,Danita H. Schuurhuis,Joannes F.M. Jacobs,Kalijn F. Bol,Gerty Schreibelt,Roel Mus,Johannes H.W. de Wilt,John B.A.G. Haanen,Dirk Schadendorf,Alexandra Croockewit,Willeke A.M. Blokx,Michelle M. van Rossum,William W. Kwok,Gosse J. Adema,Cornelis J.A. Punt,Carl G. Figdor	131
13	Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell–Based Vaccination in Metastatic Melanoma 2012 ·Cancer Research ·Erik H.J.G. Aarntzen,Kalijn F. Bol,Gerty Schreibelt,Joannes F.M. Jacobs,W. Joost Lesterhuis,Michelle M. van Rossum,Gosse J. Adema,Carl G. Figdor,Cornelis J.A. Punt,I. Jolanda M. de Vries	42
14	Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients 2012 ·Clinical Cancer Research ·Erik H.J.G. Aarntzen,Gerty Schreibelt,Kalijn F. Bol,W. Joost Lesterhuis,Alexandra Croockewit,Johannes H.W. de Wilt,Michelle M. van Rossum,Willeke A.M. Blokx,Joannes F.M. Jacobs,Tjitske Duiveman‐de Boer,Danita H. Schuurhuis,Roel Mus,Kris Thielemans,I. Jolanda M. de Vries,Carl G. Figdor,Cornelis J.A. Punt,Gosse J. Adema	80
15	Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination 2011 ·Clinical Cancer Research ·Sasja F. Mulder,Joannes F.M. Jacobs,(unknown),Joep M.D. Galama,Ingrid M.E. Desar,Ruurd Torensma,Steven Teerenstra,Peter F.A. Mulders,Kris Vissers,Cornelis J.A. Punt,I. Jolanda M. de Vries,Carla M.L. van Herpen	27
16	Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer 2011 ·Clinical Cancer Research ·Maarten J. Deenen,Jolien Tol,Artur M Burylo,Valerie D. Doodeman,Anthonius de Boer,Andrew Vincent,Henk‐Jan Guchelaar,Paul H.M. Smits,Jos H. Beijnen,Cornelis J.A. Punt,Jan H.M. Schellens,Annemieke Cats	150
17	Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients 2011 ·Clinical Cancer Research ·W. Joost Lesterhuis,I. Jolanda M. de Vries,Gerty Schreibelt,Annechien J.A. Lambeck,Erik H.J.G. Aarntzen,Joannes F.M. Jacobs,Nicole M. Scharenborg,Mandy W.M.M. van de Rakt,Annemiek J. de Boer,Sandra Croockewit,Michelle M. van Rossum,Roel Mus,Wim J.G. Oyen,Otto C. Boerman,Sophie Lucas,Gosse J. Adema,Cornelis J.A. Punt,Carl G. Figdor	138
18	Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancerbreakdown → 2010 ·Journal of Clinical Oncology ·Marc Peeters,Timothy Price,Andrés Cervantes,Alberto Sobrero,Michel Ducreux,Yevhen Hotko,Thierry André,Emily Chan,Florian Lordick,Cornelis J.A. Punt,Andrew Strickland,G. Wilson,Tudor–Eliade Ciuleanu,Laslo Roman,Eric Van Cutsem,Valentina Tzekova,Simon Collins,Kelly S. Oliner,Alan Rong,Jennifer Gansert	755
19	Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents 2010 ·Clinical Cancer Research ·I. Jolanda M. de Vries,Chiara Castelli,(unknown),Joannes F.M. Jacobs,Julie Stockis,Beatrice Schuler‐Thurner,Gosse J. Adema,Cornelis J.A. Punt,Licia Rivoltini,Gerold Schuler,Pierre G. Coulie,Sophie Lucas	64
20	Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody 2005 ·Blood ·Paul J. Tacken,I. Jolanda M. de Vries,Karlijn Gijzen,Ben Joosten,Dayang Wu,Russell P. Rother,Susan J. Faas,Cornelis J.A. Punt,Ruurd Torensma,Gosse J. Adema,Carl G. Figdor	219

About Cornelis J.A. Punt

Cornelis J.A. Punt is a scholar working on Oncology, Hepatology and Pathology and Forensic Medicine, having authored 392 papers that have together received 24.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (183 papers), Genetic factors in colorectal cancer (88 papers) and Hepatocellular Carcinoma Treatment and Prognosis (61 papers). The work is most often cited by research in Oncology (16.6k citations), Hepatology (2.8k citations) and Immunology (5.6k citations). Cornelis J.A. Punt has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Miriam Koopman, I. Jolanda M. de Vries, Carl G. Figdor, W. Joost Lesterhuis, Gosse J. Adema, J. Han van Krieken, Irıs D. Nagtegaal, Jolien Tol, Linda Mol and Leon W.M.M. Terstappen. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact